Skip to content

Market capitalization at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$3.72B+213%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$3.02B+2.7%
Avanos Medical logo
Avanos MedicalAVNS
$651.57M-1.2%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$915.07M-20.4%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
$2.98B+62.8%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$835.73M+89.2%

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×

Where this comes from

Computed from the period-end share price: $1.05B.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s market capitalization?
Collegium Pharmaceutical, Inc. (COLL) reported market capitalization of $1.05B in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s market capitalization changed year-over-year?
Collegium Pharmaceutical, Inc.'s market capitalization increased by 9.5% year-over-year, from $959.13M to $1.05B.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s market capitalization has grown at a 16.1% compound annual growth rate (CAGR), from $692.41M to $1.46B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.